**Question:** Neurofibromatosis I is a genetic disorder characterized by the overgrowth of nerve sheath tumors. It is caused by mutations in the NF1 gene, which encodes for a protein called neurofibromin. What is the correct answer?

**Core Concept:**
Neurofibromatosis I is a disorder that affects the nervous system. It is caused by mutations in the NF1 gene, which leads to a reduced function of the protein neurofibromin. Neurofibromin is a negative regulator of the Ras protein, which plays a crucial role in cell growth and differentiation. In the absence of functional neurofibromin, Ras becomes hyperactive, leading to uncontrolled cell proliferation and formation of benign tumors called neurofibromas and café-au-lait macules.

**Why the Correct Answer is Right:**
Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of benign tumors called neurofibromas and café-au-lait macules due to mutations in the NF1 gene. This gene encodes for the protein neurofibromin, which negatively regulates the Ras protein. The reduced function of neurofibromin leads to hyperactivation of Ras, promoting uncontrolled cell proliferation and tumor formation.

**Why Each Wrong Option is Incorrect:**
A. This option is incorrect because it does not address the genetic basis of the disease and the role of the NF1 gene.
B. This option is incorrect as it does not focus on the molecular mechanism of neurofibromin and Ras protein interaction in NF1.
C. This option is incorrect as it does not provide a clear explanation of the genetic cause and molecular mechanism of neurofibromatosis type 1.
D. This option is incorrect because it does not address the role of the NF1 gene and neurofibromin in the development of neurofibromas and café-au-lait macules.

**Clinical Pearl:**
Neurofibromatosis type 1 is an important genetic disorder to recognize due to its clinical manifestations and potential complications, including pain, functional impairment, and malignant progression to malignant peripheral nerve sheath tumors (MPNSTs). Early diagnosis and management are essential to improve the quality of life and reduce the risk of complications.